共 7 条
[1]
[2]
[3]
Nitric oxide; a janus-faced therapeutic target for diabetic microangiopathy—Friend or foe?[J] Sho-ichi Yamagishi;Takanori Matsui Pharmacological Research 2011,
[4]
Altered regulation of renal nitric oxide and atrial natriuretic peptide systems in angiotensin II-induced hypertension[J] Eun Hui Bae;Seong Kwon Ma;JongUn Lee;Soo Wan Kim Regulatory Peptides 2011,
[5]
Peroxynitrite—An ugly biofactor?[J] PaoloAscenzi;Alessandradi Masi;ClaraSciorati;EmilioClementi BioFactors 2010,
[6]
Randomised Controlled Trial Of Dual Blockade Of Renin-Angiotensin System In Patients With Hypertension; Microalbuminuria; And Non-Insulin Dependent Diabetes: The Candesartan And Lisinopril Microalbuminuria (Calm) Study[J] Carl Erik Mogensen;Steen Neldam;Ilkka Tikkanen;Shmuel Oren;Reuven Viskoper;Richard W. Watts;Mark E. Cooper BMJ: British Medical Journal 2000,
[7]
Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumour necrosis factor-α and inducible nitric oxide synthase in diabetic rat glomeruli[J] H. Sugimoto;K. Shikata;J. Wada;S. Horiuchi;H. Makino Diabetologia 1999,

